Загрузка...
Treating ALK-positive non-small cell lung cancer
Targeting genomic alterations, such as epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements, have radically changed the treatment of patients with non-small cell lung cancer (NSCLC). In the case of ALK-rearranged gene, subsequent rapid developmen...
Сохранить в:
| Опубликовано в: : | Ann Transl Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952030/ https://ncbi.nlm.nih.gov/pubmed/29862230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.11.34 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|